| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/06/2003 | CN1117156C Non self-inactivating, expression targeted retroviral vectors |
| 08/06/2003 | CN1117148C Vaccineforinfections agents, compositions for treating and preventing HIV infections |
| 08/06/2003 | CN1116898C Oral immune globulin preparation and its preparing process |
| 08/06/2003 | CN1116896C Powder medicine and preparation process thereof |
| 08/06/2003 | CN1116893C Preparation for treating child virus diarrhea |
| 08/06/2003 | CN1116891C Hepatitis B treating medicine and preparation process thereof |
| 08/06/2003 | CN1116890C Medicine for treating hepatitis B |
| 08/06/2003 | CN1116889C Chinese medicine preparation for rheumatic and rheumatoid diseases |
| 08/06/2003 | CN1116887C Defervescent and its preparing process |
| 08/06/2003 | CN1116885C Medicine for treating piles |
| 08/06/2003 | CN1116882C Chinese medicine composition for curing spur and hyperosteoeny and its preparing method |
| 08/06/2003 | CN1116880C Use of puffer liver oil in preparing food for curing poisonous drug dependence |
| 08/06/2003 | CN1116879C Process for preparing compound pancreatic ribonucleate for injection |
| 08/06/2003 | CN1116822C Process for preparing nutritive embryo powder and hydrolyzed pearl powder |
| 08/06/2003 | CN1116815C Production process of bee gathering honey |
| 08/05/2003 | US6602975 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 08/05/2003 | US6602952 Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers |
| 08/05/2003 | US6602902 Dha-pharmaceutical agent conjugates to improve tissue selectivity |
| 08/05/2003 | US6602709 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |
| 08/05/2003 | US6602706 Cell comprising nucleotide sequence encoding viral gene product and recombinant nucleic acids lacking overlapping sequences; virus unable to replicate; use in treatment of genetic disorders and autoimmune diseases; antitumor agent |
| 08/05/2003 | US6602680 Production of gabaergic cells |
| 08/05/2003 | US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 08/05/2003 | US6602499 Viral mutants for selectively killing neoplastic cells; herpes simplex virus vector; transgene encoding cytochrome P450, chemotherapeutic agent activated by cytochrome P450; viral mediated oncolysis and anticancer "suicide" gene therapy |
| 08/05/2003 | CA2329259C Convection-enhanced delivery of aav vectors |
| 07/31/2003 | WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 07/31/2003 | WO2003062414A2 Methods of obtaining isoform specific expression in mammalian cells |
| 07/31/2003 | WO2003062405A2 Method for inducing differentiation of embryonic stem cells |
| 07/31/2003 | WO2003062404A1 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
| 07/31/2003 | WO2003062384A2 Stem cell maturation for all tissue types |
| 07/31/2003 | WO2003062369A2 Expansion of renewable stem cell populations |
| 07/31/2003 | WO2003062274A1 Novel proteins and dnas thereof |
| 07/31/2003 | WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies |
| 07/31/2003 | WO2003061708A1 Stabilized formulations of adenovirus |
| 07/31/2003 | WO2003061690A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives |
| 07/31/2003 | WO2003061682A1 The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus |
| 07/31/2003 | WO2003061675A1 Biologically active additive to food and method for producing said additive |
| 07/31/2003 | WO2003061674A1 Dietary supplements comprising growth media |
| 07/31/2003 | WO2003061622A2 Method and device for feeding living cells into a biological body fluid |
| 07/31/2003 | WO2003061591A2 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
| 07/31/2003 | WO2003061560A2 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 07/31/2003 | WO2003061392A1 Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof |
| 07/31/2003 | WO2003035679A3 Molecules |
| 07/31/2003 | WO2003025140A3 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/31/2003 | WO2003010243A3 Multipotent stem cells from peripheral tissues and uses thereof |
| 07/31/2003 | WO2003006607A3 Inhibition of apoptosis process and improvement of cell performance |
| 07/31/2003 | WO2002098453A3 Orally administering parathyroid hormone and calcitonin |
| 07/31/2003 | WO2002039885A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/31/2003 | WO2002024897A3 Conditionally replicating viral vectors and their use |
| 07/31/2003 | WO2002004010A3 Inhibition of tumor growth by a nematode anticoagulant protein |
| 07/31/2003 | US20030144248 Surfactant prevention of lung complications from cancer chemotherapy |
| 07/31/2003 | US20030144239 Expression system |
| 07/31/2003 | US20030144232 Expression system |
| 07/31/2003 | US20030144180 Contains as active ingredient a therapeutically effective amount of agent for either enhancing protein kinase c production and/or activation |
| 07/31/2003 | US20030144176 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
| 07/31/2003 | US20030143739 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 07/31/2003 | US20030143737 Long-term cell-culture compositions and genetically modified animals derived therefrom |
| 07/31/2003 | US20030143730 The viral DNA is introduced into a culture of encapsidation cells and the viruses produced are harvested following release into the supernatant such as by ultrafiltration; use of iodixanol for purification of adenoviruses |
| 07/31/2003 | US20030143620 Carbohydrate ligands specific for MHC molecules |
| 07/31/2003 | US20030143518 Drying liquid blood plasma to a granular form in a bed of heated fluidizing gas, monitoring the temperature so as not to exceed the maximum acceptable temperature; biological activity of the protein is not lost |
| 07/31/2003 | US20030143285 For therapy andprophylaxis of disease-like conditions caused by extreme body fluid discharge |
| 07/31/2003 | US20030143284 Food product comprising a high level of natural anti-secretory protein |
| 07/31/2003 | US20030143283 Bone repair material |
| 07/31/2003 | US20030143281 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 07/31/2003 | US20030143248 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 07/31/2003 | US20030143238 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/31/2003 | US20030143211 Providing a platelet-containing fluid sample at a first temperature; adding to the sample, an amount of an exothermic salt sufficient to activate the platelets |
| 07/31/2003 | US20030143209 For gene therapy of cancers or cardiovascular conditions |
| 07/31/2003 | US20030143208 For therapy of neurodegenerative disorders associated with oxidative damage and subsequent neuronal cell loss, including, but not limited to, Parkinson's disease and head trauma |
| 07/31/2003 | US20030143207 Remodeling of tissues and organ |
| 07/31/2003 | US20030141185 Contact assemblies, methods for making contact assemblies, and machines with contact assemblies for electrochemical processing of microelectronic workpieces |
| 07/31/2003 | CA2511257A1 Stimulation of bone growth and cartilage formation with thrombin peptide derivatives |
| 07/31/2003 | CA2474766A1 Stem cell maturation for all tissue types |
| 07/31/2003 | CA2474344A1 Expansion of renewable stem cell populations |
| 07/31/2003 | CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 07/31/2003 | CA2472241A1 The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus |
| 07/31/2003 | CA2469721A1 Stabilized formulations of adenovirus |
| 07/30/2003 | EP1331264A1 Method of culturing human chondrocytes |
| 07/30/2003 | EP1331009A1 Medicinal compositions for promoting recovery from stress loading and novel matsutake mushroom strain |
| 07/30/2003 | EP1331006A1 Dietary supplements comprising growth media |
| 07/30/2003 | EP1330548A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 07/30/2003 | EP1330514A1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 07/30/2003 | EP1330265A1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 07/30/2003 | EP1330262A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 07/30/2003 | EP1330259A2 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
| 07/30/2003 | EP1330253A1 Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients |
| 07/30/2003 | EP1330252A1 In vivo stimulation of angiogenic activity |
| 07/30/2003 | EP0983074B1 Non-myeloablative tolerogenic treatment |
| 07/30/2003 | EP0981355B1 Treatment of chronic inflammatory diseases with cm101/gbs toxin |
| 07/30/2003 | EP0833923B1 Immunogenic construct, process for its preparation and use as a vaccine |
| 07/30/2003 | EP0811412B1 Filter medium for leukocyte removal |
| 07/30/2003 | EP0769954B1 Medicament of assured quality, containing one or more plasma derivatives |
| 07/30/2003 | CN1433472A Production of vaccines |
| 07/30/2003 | CN1433466A MASP-3, complement-fixing enzyme, and uses for it |
| 07/30/2003 | CN1433325A Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 07/30/2003 | CN1433318A Vascular endothelial growth factor-2 |
| 07/30/2003 | CN1432396A Chinese medicine prepn for treating nephropathy and its prepn |
| 07/30/2003 | CN1432394A Medicine for treating stomach trouble |
| 07/30/2003 | CN1432390A External medicine for treating sterility and women's diseases and its prepn |
| 07/30/2003 | CN1432389A Xuerongguyugao ointment for healing fracture and its prepn |
| 07/30/2003 | CN1432384A Ointment for removing necrosis, promoting granulation and invigorating bone and its prepn |